Digestive System Neoplasms Therapy
Research from Erasmus Medical Center, Department of Surgical Oncology in digestive system neoplasms therapy provides new insights
Published in Hospital Law Weekly, July 24th, 2008
Data detailed in 'Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis' have been presented. According to recent research from Rotterdam, Netherlands, "Gastrointestinal stromal tumors (GIST) are the most common malignant mesenchymal tumors of the gastrointestinal tract. The principal treatment modality for primary GIST is surgery whereas for metastatic GIST, imatinib has an established role."
"In patients with locally advanced and metastatic GIST, the role of surgery in the imatinib era is still...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2008-07-24)
More Articles from Hospital Law Weekly
- Avalere Health
Avalere Examines Emerging Strategies for Managing Imaging Utilization - Bone Research
Study results from University of Leuven, Medical Department provide new insights into bone research - Coalition for a Working Oregon
Newly-Released Study Predicts Economic Pain for Oregon if Federal Immigration Regulations are Implemented - Consejo de Latinos Unidos
Death of Hortensia R. Magana - Council for Quality Respiratory Care
Home Oxygen Care Leaders Applaud U.S. Senate for Passing Medicare Bill to Improve and Protect Home Oxygen Benefit - Fresenius Medical Care
Fresenius Medical Care Signs Agreements for Intravenous Iron Products - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
